People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Envisia Therapeutics Inc. | — | Other Health Care | Series B | $15.2M | $337.0M | 2013 |
| LQ3 Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $4.4M | $89.5M | 2014 |
Tim Albury at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tim Albury on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Neal Fowler | 2 | 4 |
| Stephen Bloch | 1 | 15 |
| Seth Rudnick | 1 | 5 |
| Kyle Chenet | 1 | 2 |
| Shawn Glidden | 1 | 1 |
| Shawn 22709 Glidden | 1 | 1 |
| Seth 22709 Rudnick | 1 | 1 |
| Ed 22709 Mathers | 1 | 1 |
| Stephen 22709 Bloch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.